A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey

PLoS One. 2012;7(10):e47289. doi: 10.1371/journal.pone.0047289. Epub 2012 Oct 8.

Abstract

Background: China is experiencing a dynamic HIV/AIDS epidemic. While serology based surveillance systems have reported the spread of HIV/AIDS, detailed tracking of its transmission in populations and regions is not possible without mapping it at the molecular level. We therefore conducted a nationwide molecular epidemiology survey across the country.

Methods: HIV-1 genotypes were determined from 1,408 HIV-positive persons newly diagnosed in 2006. The prevalence of each genotype was estimated by weighting the genotype's prevalence from each province- and risk-specific subpopulation with the number of reported cases in the corresponding subgroups in that year.

Results: CRF07_BC (35.5%), CRF01_AE (27.6%), CRF08_BC (20.1%), and subtype B' (9.6%) were the four main HIV-1 strains in China. CRF07_BC and CRF08_BC were the primary drivers of infection among injecting drug users in northeastern and southeastern China, respectively, and subtype B' remained dominant among former plasma donors in central China. In contrast, all four strains occurred in significant proportions among heterosexuals nationwide, pointing to an expansion of the HIV-1 epidemic from high-risk populations into the general population. CRF01_AE also replaced subtype B as the principal driver of infection among men-who-have-sex-with-men.

Conclusions: Our study provides the first comprehensive baseline data on the diversity and characteristics of HIV/AIDS epidemic in China, reflecting unique region- and risk group-specific transmission dynamics. The results provide information critical for designing effective prevention measures against HIV transmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Female
  • Genotype
  • HIV Infections / epidemiology*
  • HIV Infections / genetics
  • HIV-1 / classification
  • HIV-1 / genetics*
  • HIV-1 / pathogenicity*
  • Humans
  • Male
  • Molecular Epidemiology

Grants and funding

This work was supported by the Chinese 863 Program (2006AA022418), National Science and Technology Major Project for Infectious Diseases Control and Prevention (2008ZX10001-004, 010, 2012ZX10001-002, 008), and International Cooperative Grant (2009DFB30420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.